日本語
BATON BATON

Dementia diagnosis based on blood tests:
Accelerating its application

Contributing to early dementia diagnosis
and the development of effective methods
of prevention and treatment

A research group centered at the National Center for Geriatrics and Gerontology has embarked on a multicenter research collaboration between industry and academia that is developing a system for comprehensive stratification of dementia using blood biomarkers, aimed at the practical application of a system to diagnose dementia and predict the risk of its occurrence with blood tests.

Called the Blood-based Amyloid, Tau and Other Neuropathological Biomarkers (BATON) project the project is supported by the Japan Agency for Medical Research and Development and is being conducted as a collaborative research effort involving the Tokyo Metropolitan Geriatrics Hospital, National Institutes for Quantum and Radiological Science and Technology, Kindai University, Nagoya University, Shimadzu Corporation, BioSHIP, and Toray Industries, Inc.


				National Center for Geriatrics and Gerontology
				Tokyo Metropolitan Institute of Gerontology
				National Institutes for Quantum and Radiological Science and Technology
				Kindai University Faculty of Medicine
				Nagoya University Graduate School of Medicine
				Shimadzu Corporation
				Toray Industries, Inc.
				BioSHIP
Project

Project

An introduction to the BATON project, which aims for the application of a system for comprehensive stratification of dementia using blood biomarkers.

Learn More
Research organization

Research organization

An introduction to the research group of the BATON project, a multicenter research collaboration between industry and academia.

Learn More